Timothy Perk

637 total citations
38 papers, 468 citations indexed

About

Timothy Perk is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Timothy Perk has authored 38 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Radiology, Nuclear Medicine and Imaging, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Timothy Perk's work include Medical Imaging Techniques and Applications (22 papers), Prostate Cancer Treatment and Research (20 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Timothy Perk is often cited by papers focused on Medical Imaging Techniques and Applications (22 papers), Prostate Cancer Treatment and Research (20 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Timothy Perk collaborates with scholars based in United States, China and Slovenia. Timothy Perk's co-authors include Robert Jeraj, Glenn Liu, Stephanie A. Harmon, Scott B. Perlman, Meijie Chen, Jens C. Eickhoff, Yaming Li, Xuena Li, Song Chen and Tyler Bradshaw and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Timothy Perk

35 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Perk United States 12 352 247 140 70 55 38 468
Urban Simončič Slovenia 11 247 0.7× 138 0.6× 98 0.7× 49 0.7× 18 0.3× 33 394
Srishti Abrol United States 8 231 0.7× 86 0.3× 96 0.7× 46 0.7× 18 0.3× 12 335
Diem Vuong Switzerland 13 309 0.9× 153 0.6× 113 0.8× 95 1.4× 16 0.3× 24 385
Virginia Liberini Italy 14 282 0.8× 149 0.6× 204 1.5× 51 0.7× 15 0.3× 33 467
Jingmian Zhang China 8 228 0.6× 152 0.6× 108 0.8× 29 0.4× 10 0.2× 31 312
Yankai Meng China 11 278 0.8× 76 0.3× 223 1.6× 71 1.0× 12 0.2× 24 423
Z Y Li China 3 196 0.6× 194 0.8× 80 0.6× 39 0.6× 10 0.2× 9 333
Lan He China 7 399 1.1× 184 0.7× 106 0.8× 137 2.0× 8 0.1× 8 498
Weicai Huang China 9 233 0.7× 180 0.7× 114 0.8× 36 0.5× 14 0.3× 14 397
Bernadette Redd United States 8 133 0.4× 98 0.4× 163 1.2× 18 0.3× 54 1.0× 24 366

Countries citing papers authored by Timothy Perk

Since Specialization
Citations

This map shows the geographic impact of Timothy Perk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Perk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Perk more than expected).

Fields of papers citing papers by Timothy Perk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Perk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Perk. The network helps show where Timothy Perk may publish in the future.

Co-authorship network of co-authors of Timothy Perk

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Perk. A scholar is included among the top collaborators of Timothy Perk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Perk. Timothy Perk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murthy, Vishnu, Andrew Nguyen, Timothy Perk, et al.. (2025). Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with 177 Lu-PSMA: A Retrospective, Single-Center Study. Journal of Nuclear Medicine. 66(11). 1690–1694.
2.
Weisman, Amy J., et al.. (2025). Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 66(4). 565–571. 3 indexed citations
3.
Gray, Elin S., et al.. (2024). Correlation of ctDNA and radiographic imaging features derived from 18F-FDG PET/CT for patients with metastatic melanoma treated with immunotherapy.. Journal of Clinical Oncology. 42(16_suppl). 3057–3057. 1 indexed citations
4.
Murthy, Vishnu, Timothy Perk, Lucia Chen, et al.. (2024). Baseline PSMA PET/CT as a predictive biomarker for toxicity and patient-reported outcomes in mCRPC patients undergoing 177Lu-PSMA radioligand therapy.. Journal of Clinical Oncology. 42(16_suppl). e17058–e17058. 1 indexed citations
5.
Govindan, Rajkumar Munian, et al.. (2024). Assessing the Heterogeneity of Response of [68Ga] Ga-PSMA-11 PET/CT Lesions in Patients With Biochemical Recurrence of Prostate Cancer. Clinical Genitourinary Cancer. 22(5). 102155–102155. 2 indexed citations
6.
Levi, Jelena, Millie Das, Deepti Behl, et al.. (2024). [18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy. Journal of Nuclear Medicine. 65(12). jnumed.124.268253–jnumed.124.268253. 1 indexed citations
7.
Perk, Timothy, Amy J. Weisman, Rajkumar Munian Govindan, et al.. (2024). Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome. European Journal of Nuclear Medicine and Molecular Imaging. 51(12). 3505–3517. 5 indexed citations
9.
Gandhy, Shruti U., Fatima Karzai, Marijo Bilušić, et al.. (2023). Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide. European Urology Oncology. 7(4). 735–741. 1 indexed citations
10.
Weisman, Amy J., et al.. (2023). Multi-organ segmentation of CT via convolutional neural network: impact of training setting and scanner manufacturer. Biomedical Physics & Engineering Express. 9(6). 65021–65021. 3 indexed citations
11.
Chen, Song, Meijie Chen, Carl Kashuk, et al.. (2023). Performance of an automated registration-based method for longitudinal lesion matching and comparison to inter-reader variability. Physics in Medicine and Biology. 68(17). 175031–175031. 8 indexed citations
13.
Weisman, Amy J., et al.. (2022). Comparison of automated full-body bone metastases delineation methods and their corresponding prognostic power. Physics in Medicine and Biology. 68(3). 35011–35011. 11 indexed citations
14.
Scarpelli, M, et al.. (2021). Development and validation of a longitudinal soft-tissue metastatic lesion matching algorithm. Physics in Medicine and Biology. 66(15). 155017–155017. 9 indexed citations
15.
Roth, Alison, Stephanie A. Harmon, Timothy Perk, et al.. (2019). Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 17(4). 306–314. 2 indexed citations
16.
Chen, Song, Stephanie A. Harmon, Timothy Perk, et al.. (2019). Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules. Cancer Imaging. 19(1). 56–56. 41 indexed citations
17.
Perk, Timothy, Stephanie A. Harmon, Tyler Bradshaw, et al.. (2018). A statistically optimized regional thresholding method (SORT) for bone lesion detection in 18F-NaF PET/CT imaging. Physics in Medicine and Biology. 63(22). 225018–225018. 15 indexed citations
18.
Weisman, Amy J., Stephanie A. Harmon, Timothy Perk, et al.. (2018). Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 22(2). 324–330. 11 indexed citations
19.
Bradshaw, Tyler, Timothy Perk, Stephanie A. Harmon, et al.. (2016). Repeatability of Quantitative 18F-NaF PET: A Multicenter Study. Journal of Nuclear Medicine. 57(12). 1872–1879. 55 indexed citations
20.
Bradshaw, Tyler, et al.. (2015). TU-AB-BRA-05: Repeatability of [F-18]-NaF PET Imaging Biomarkers for Bone Lesions: A Multicenter Study. Medical Physics. 42(6Part31). 3587–3587. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026